A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery

被引：41

作者：

Riess, FC

Potzsch, B

Bader, R

Bleese, N

Greinacher, A

Lower, C

Madlener, K

MullerBerghaus, G

机构：

[1] Department of Cardiac Surgery and Cardiac Anaesthesiology, Albertinen-Krankenhaus, D-22457 Hamburg

[2] Haemostasis Research Unit, Max-Planck-Institut für Physiologische und Klinische Forschung, Kerckhoff-Klinik, Bad Nauheim

[3] Department of Transfusion Medicine, Ernst-Moritz-Arndt-University Greifswald

来源：

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 1996年 / 10卷 / 05期

关键词：

recombinant hirudin; anticoagulation; heparin-induced thrombocytopenia; cardiopulmonary bypass; open heart surgery;

D O I：

10.1016/S1010-7940(96)80100-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present a patient with coronary heart disease and a heparin-induced thrombocytopenia, who was successfully treated by coronary artery bypass grafting (CABG) using recombinant hirudin as an anticoagulant for cardiopulmonary bypass (CPB) instead of heparin.

引用

页码：386 / 388

页数：3

共 13 条

[1] HIRUDIN IN HEMODIALYSIS [J].

BUCHA, E ;

MARKWARDT, F ;

NOWAK, G .

THROMBOSIS RESEARCH, 1990, 60 (06) :445-455

[2]

FAREED D, 1989, FASEB Journal, V3, pA308

[3]

GLUSA E, 1990, HAEMOSTASIS, V20, P112

[4] INTERFERENCE OF HEPARIN AND ANALOGS WITH HIRUDIN IN THE CHROMOGENIC THROMBIN SUBSTRATE ASSAY [J].

GROETSCH, H ;

BERSCHEID, G ;

HROPOT, M ;

BENYOUSSEF, R .

THROMBOSIS RESEARCH, 1991, 64 (02) :285-290

[5] DIE ISOLIERUNG UND CHEMISCHE CHARAKTERISIERUNG DES HIRUDINS [J].

MARKWARDT, F .

HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1957, 308 (2-4) :147-156

[6]

MARKWARDT F, 1988, PHARMAZIE, V43, P202

[7]

MULLERBERGHAUS G, 1992, THROMBOSIS UPDATE, P133

[8]

MURPHY DA, 1984, J THORAC CARDIOV SUR, V87, P789

[9]

NOWAK G, 1993, THROMB HAEMOSTASIS, V69, pA2736

[10]

POTZSCH B, 1994, ANN HEMATOL, V68, pA53

← 1 2 →